CUTANEOUS INVOLVEMENT IN MULTIPLE MYELOMA IN THE ERA OF PROTEASOME INHIBITORS: HAS THE DISMAL PROGNOSIS CHANGED?
Autor: | Piazera, FZ, Costa, AR, Lima, GR, Maldonado, JVO, Bitencourte, HM, Vasconcelos, RS |
---|---|
Zdroj: | In Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S264-S264 |
Databáze: | ScienceDirect |
Externí odkaz: |